CAS No.:4076-02-2

TOXICITY DATA with REFERENCE：

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
mouse	LD50	intraperitoneal	1098mg/kg (1098mg/kg)		Toxicology and Applied Pharmacology. Vol. 61, Pg. 385, 1981.
mouse	LD50	subcutaneous	1gm/kg (1000mg/kg)		Farmakologiya i Toksikologiya Vol. 23, Pg. 355, 1960.
rat	LD50	intraperitoneal	1055mg/kg (1055mg/kg)	BEHAVIORAL: EXCITEMENT BEHAVIORAL: WITHDRAWAL SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE"	Arzneimittel-Forschung. Drug Research. Vol. 30, Pg. 1291, 1980.
rat	LD50	subcutaneous	1500mg/kg (1500mg/kg)	BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: MUSCLE WEAKNESS LUNGS, THORAX, OR RESPIRATION: DYSPNEA	Farmakologiya i Toksikologiya Vol. (6), Pg. 91, 1971.

Consensus Reports：

 

SAFETY PROFILE：

Hazard Codes Xi
Risk Statements 36/37/38
Safety Statements 24/25-36-26
Hazard Codes: Xi
Risk Statements about DMPS (CAS No.:4076-02-2):
R36/37/38:Irritating to eyes, respiratory system and skin.
Safety Statements about DMPS (CAS No.:4076-02-2):
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. 
S36:Wear suitable protective clothing. 
S24/25:Avoid contact with skin and eyes.

Standards and Recommendations：

 

Analytical Methods：